EFFECTIVENESS OF BOTULINUM TOXIN IN MYOFASCIAL PAIN

Abstract

Myofascial pain syndrome consists of a disease that affects 3% to 5% of the population. One of the treatments is Botulinum Toxin, as it inhibits the hyperactivity of the affected musculature, caused specifically by the inappropriate release of acetylcholine in the motor plate. The aim of this study was to analyze the effectiveness of Botox in the treatment of such disease. It consists of an integrative literature review in which a search was performed on the PubMed and VHL platforms. Following the inclusion and exclusion criteria, 25 articles were selected in the article. Through studies analyzed, it was observed that the use of Botulinum Toxin, although not the treatment of choice for the treatment of Myofascial pain, proved to be efficient when applied to the trigger points present in the affected musculature. Although the pathophysiology of this muscle disorder is unclear and multifactorial, the use of Botox in its treatment has proved to be a beneficial option. In conclusion, a correct diagnosis is required for there to be a good prognosis with use of the toxin in the treatment.